Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study of Citicoline Add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
This study has been completed.
Study NCT00377299 Information provided by University of Texas Southwestern Medical Center
First Received on September 14, 2006. Last Updated on May 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amphetamine Abuse
Amphetamine Dependence
Bipolar Disorder
Major Depressive Disorder
Additional conditions recognized in this trial
Amphetamine-Related Disorders
Depression
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Substance-Related Disorders
Interventions listed in this trial
Citicoline (supplement)
Additional drug interventions recognized in this trial
Amphetamine
Cytidine Diphosphate Choline
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Nootropic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
University of Texas Southwestern Medical Center
Stanley Medical Research Institute
Back to top of Main Content
